REVIEW PAPER
THE SUFFERING OF PATIENTS WITH RESPIRATORY DISORDERS DURING SLEEP
More details
Hide details
Publication date: 2013-11-26
Medical Studies 2013;29(1):95-101
KEYWORDS
ABSTRACT
Assumption: Respiratory disorders during sleep involving the occurrence of sleep apnoea leading to a reduction in arterial oxygen saturation are classified as: obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation with hypoxaemia. A close correlation has been proved between the occurrence of apnoea and obesity. This problem concerns 2–4% of the population, and is more likely to affect men.
Aim: Presentation of the problem of respiratory disorders during sleep as a chronic disease causing much suffering. Its symptoms may lead to sleep fragmentation and somatic consequences (such as dysfunction of the cardiovascular system) as well as mental consequences (personality changes).
Method: An analysis of literature concerning the subject-matter from the perspective of a doctor conducting ventilation therapy of patients with respiratory sleep disorders.
Summary: The problem of sleep apnoea is most often diagnosed and treated too late due to the number of symptoms with a simultaneous absence of pathognomonic symptoms. Despite its commonness, recognition of this disease is still insufficient.
REFERENCES (32)
1.
Leśna K, Batura-Gabryel H. Ocena stanu wiedzy na temat zespołu bezdechu śródsennego jako problemu społecznego i zdrowotnego wśród mieszkańców Poznania. Nowiny Lekarskie 2011; 80(2): 98–103.
2.
Batura-Gabryel H, Cofta S. Zespół bezdechu w czasie snu. Endokr. Otyłość. Zaburzenia Przemiany Materii 2007; 3: 2.
3.
Mazur-Stążka M. Zaburzenia oddychania w czasie snu – cz. 1. Służ Zdr 2008; 22–25(3723–3726): 46–48.
4.
American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine 2005.
5.
Ruehland WR, Rochford PD, O’Donoghue FJ et al. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 2009; 32(2): 150–157.
6.
Pływaczewski R. Częstość i nasilenie zaburzeń oddychania w czasie snu wśród dorosłej populacji prawobrzeżnej Warszawy (praca habilitacyjna 2003 r., Instytut Gruźlicy i Chorób Płuc w Warszawie).
7.
Gross JB, Bachenberg KL, Benumof JL et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104(5): 1081–1093.
8.
Eckert DJ, Jordan AS, Mericha P et al. Central sleep apnea: pathophysiology and treatment. Chest 2007; 131(2): 595–607.
9.
Malthora A, Owens RL. What is central apnea. Respiratory Care 2012; 55, 9.
10.
Randerath WJ, Galetke W, Stilglitz S et al. Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnea and Cheyne-Stokes respiration. Sleep Medicine 9 2008; 823–830.
11.
Arzt M, Wensel R, Montalvan S. Effects of Dynamic Bilevel Positive Airway Pressure Support on Central Sleep Apnea in Men With Heart Failure. Chest 2008; 134, 1.
12.
Dernaika T, Tawk M, Nazir S. The significance and outcome of continuous positive airway pressurerelated central sleep apnea during split-night sleep studies. Chest 2007; 132(1): 81–87.
13.
Bitter T, Westerheide N, Sajid Hossain M et al. Complex sleep apnoea in congestive heart failure. Thorax 2011.
14.
Hasiec A, Szumowski Ł, Walczak F. Obturacyjny bezdech – senny zabójca. Forum Medycyny Rodzinnej 2012; 6(30): 103–114.
15.
Berger G, Berger R, Oksenberg A. Progression of snoring and obstructive sleep apnoea: the role of increasing weight and time. Eur. Respir J. 2009; 33(2): 338–345.
16.
Qureshi A, Ballard R, Nelson H. Obstructive sleep apnea. The Journal of Allergy and Clinical Immunology 2003; 112(4); 643–651.
17.
Sean M, Caples, DO, Apoor S et al. Obstructive Sleep Apnea. Annals of Internal Medicine 2005; 142: 187–191.
18.
Jankowska R, Brzecka A, Passowcz-Muszyń- ska E. Wydzielanie hormonu natriuretycznego w zespole obturacyjnego bezdechu sennego. Pneumonologia i Alergologia Polska 2001; 69, 11–12: 644–649.
19.
Goncalves MA, Guilleminault C, Ramos E et al. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 2005; Jul; 6(4): 333–339.
20.
Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: crosssectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19–25.
21.
Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138(2): 337–340.
22.
George CF, Smiley A. Sleep apnea & automobile crashes. Sleep 1999; 22(6): 790–795.
Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9(3): 211–224.
23.
Xie A, Skatrud JB, Puleo DS. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 2001; 91: 1555–1562.
24.
Mooe T, Franklin KA, Wiklund U et al. Sleepdisordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 2000 Jun; 117(6): 1597–1602.
25.
Alchanatis M, Tourkohoriti G, Kakouros S at al. Daytime Pulmonary Hypertension in Patients with Obstructive Sleep Apnea. Respiration 2001; 68: 566– 572.
26.
Shepard JW, Pevernagie DA, Stanson AW at al. Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 153: 250–254.
27.
Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000 Sep; 118(3): 591–595.
28.
Leung R, Huber M, Rogge T et al. Association Between Atrial Fibrillation and Central Sleep Apnea. Sleep 2005; 28, 12.
29.
Gami AS, Hodge DO, Herges RM. Obstructive Sleep Apnea, Obesity, and the Risk of IncidentAtrial Fibrillation. Am J Coll Cardiol 2007; 49(5): 565–571.
30.
NetzerNC, Stoohs RA, Netzer CM et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485–491.
31.
Wolf J, Narkiewicz K. Bezdech senny – nowe aspekty diagnostyczne i terapeutyczne. Postępy Nauk Medycznych 2011; s 3: 68–73.
32.
Lurie A. Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol. 2011; 46: 1–42.